Jetvid-OZR Oral Suspension is a combination antimicrobial and antidiarrheal formulation containing Ofloxacin 50 mg, Ornidazole 125 mg, and Racecadotril 10 mg per dose. Ofloxacin, a fluoroquinolone antibiotic, exhibits broad-spectrum bactericidal activity against gram-positive and gram-negative pathogens by inhibiting bacterial DNA gyrase and topoisomerase IV. Ornidazole, a nitroimidazole derivative, provides potent antiprotozoal and anaerobic antibacterial effects through disruption of DNA synthesis in susceptible organisms. Racecadotril, an enkephalinase inhibitor, acts as an antisecretory agent by reducing intestinal hypersecretion of water and electrolytes, thereby alleviating acute diarrhea symptoms without affecting intestinal motility. This combination is indicated for the treatment of acute infective diarrhea caused by mixed bacterial and protozoal infections, including traveler’s diarrhea and dysentery. Jetvid-OZR Oral Suspension offers rapid symptomatic relief by targeting the underlying infectious agents while controlling fluid loss to prevent dehydration. The suspension form ensures ease of administration and accurate dosing, particularly in pediatric and geriatric populations. Use should be guided by clinical diagnosis and sensitivity patterns to minimize resistance development. Caution is advised in patients with hypersensitivity to any component, and concurrent use with other neurotoxic or nephrotoxic agents should be avoided.